Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Net Cash Flow (2021 - 2025)

Lucid Diagnostics' Net Cash Flow history spans 5 years, with the latest figure at -$12.6 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 260.55% year-over-year to -$12.6 million; the TTM value through Dec 2025 reached $12.3 million, up 256.64%, while the annual FY2025 figure was $12.3 million, 256.64% up from the prior year.
  • Net Cash Flow reached -$12.6 million in Q4 2025 per LUCD's latest filing, down from $16.2 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $53.6 million in Q4 2021 to a low of -$15.2 million in Q2 2022.
  • Average Net Cash Flow over 5 years is $1.7 million, with a median of -$1.1 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: plummeted 23804.17% in 2022, then surged 3806.62% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $53.6 million in 2021, then tumbled by 108.32% to -$4.5 million in 2022, then fell by 15.56% to -$5.2 million in 2023, then skyrocketed by 252.68% to $7.9 million in 2024, then tumbled by 260.55% to -$12.6 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Net Cash Flow are -$12.6 million (Q4 2025), $16.2 million (Q3 2025), and $5.9 million (Q2 2025).